Closed

NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East

Descriptions

Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B. Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 05 - SOUTH of England Annual Tranche. Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 06 - Mids & East and North of England Regions - Bevacizumab. Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.

Timeline

Published Date :

30th Apr 2021 3 years ago

Deadline :

4th Jun 2021 3 years ago

Contract Start :

1st Sep 2021

Contract End :

31st Aug 2023

CPV Codes

Let’s Get you Started ✍

Get to see all tender details more briefly

Already have an account ?

Workflows

Status :

Closed

Assign to :

Tender Progress :

0%

Details

Notice Type :

Open opportunity

Tender Identifier :

IT-378-246-T: 2024 - 001

TenderBase ID :

310724019

Low Value :

£100K

High Value :

£1000K

Region :

North Region

Attachments :

Buyer Information

Address :

Liverpool Merseyside , Merseyside , L13 0BQ

Website :

N/A

Procurement Contact

Name :

Tina Smith

Designation :

Chief Executive Officer

Phone :

0151 252 3243

Email :

tina.smith@shared-ed.ac.uk

Possible Competitors

1 Possible Competitors